Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Wolff

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The American Journal of Cardiology|July 15, 1999
A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents. Ranolazine Study GroupC J Pepine, A A Wolff
Nederlands Tijdschrift Voor Geneeskunde|December 5, 1981
[A patient with anhidrotic ectodermal dysplasia]A A Wolff, J B Hermans
General Pharmacology|April 29, 1998
Ranolazine: a novel metabolic modulator for the treatment of anginaJ G McCormack, W C Stanley, A A Wolff
American Heart Journal|September 1, 1994
Preserved beta-adrenoceptor-mediated adenylyl cyclase activity despite receptor and postreceptor dysfunction in acute myocardial ischemiaA A Wolff, D K Hines, J S Karliner
Cardiovascular Drugs and Therapy|November 5, 1999
Lack of effect of cholesterol esterase inhibitor CVT-1 on cholesterol absorption and LDL cholesterol in humansM S Bosner, A A Wolff, R E Ostlund
The American Journal of Physiology|September 1, 1989
Refined membrane preparations mask ischemic fall in myocardial beta-receptor densityA A Wolff, D K Hines, J S Karliner
Circulation|January 1, 1996
Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat heartsJ G McCormack, R L Barr, A A Wolff, et al.
Journal of Cellular Biochemistry|April 1, 1992
Dihydropyridine calcium antagonist modulates cholesterol metabolism and eicosanoid biosynthesis in vascular cellsA C Nicholson, O R Etingin, K B Pomerantz, et al.
Alimentary Pharmacology & Therapeutics|July 15, 1998
Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infectionJ J Kolkman, T G Tan, M Oudkerk Pool, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|October 5, 2001
Electrophysiologic effects of a novel selective adenosine A1 agonist (CVT-510) on atrioventricular nodal conduction in humansB B Lerman, K A Ellenbogen, A Kadish, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The American Journal of Cardiology|July 15, 1999
A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents. Ranolazine Study GroupC J Pepine, A A Wolff
Nederlands Tijdschrift Voor Geneeskunde|December 5, 1981
[A patient with anhidrotic ectodermal dysplasia]A A Wolff, J B Hermans
General Pharmacology|April 29, 1998
Ranolazine: a novel metabolic modulator for the treatment of anginaJ G McCormack, W C Stanley, A A Wolff
American Heart Journal|September 1, 1994
Preserved beta-adrenoceptor-mediated adenylyl cyclase activity despite receptor and postreceptor dysfunction in acute myocardial ischemiaA A Wolff, D K Hines, J S Karliner
Cardiovascular Drugs and Therapy|November 5, 1999
Lack of effect of cholesterol esterase inhibitor CVT-1 on cholesterol absorption and LDL cholesterol in humansM S Bosner, A A Wolff, R E Ostlund
The American Journal of Physiology|September 1, 1989
Refined membrane preparations mask ischemic fall in myocardial beta-receptor densityA A Wolff, D K Hines, J S Karliner
Circulation|January 1, 1996
Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat heartsJ G McCormack, R L Barr, A A Wolff, et al.
Journal of Cellular Biochemistry|April 1, 1992
Dihydropyridine calcium antagonist modulates cholesterol metabolism and eicosanoid biosynthesis in vascular cellsA C Nicholson, O R Etingin, K B Pomerantz, et al.
Alimentary Pharmacology & Therapeutics|July 15, 1998
Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infectionJ J Kolkman, T G Tan, M Oudkerk Pool, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|October 5, 2001
Electrophysiologic effects of a novel selective adenosine A1 agonist (CVT-510) on atrioventricular nodal conduction in humansB B Lerman, K A Ellenbogen, A Kadish, et al.
Pageof 2